Journal of Medicinal Chemistry · 2021 · 25 citations · 18 references
PharmacyMedicinal ChemistryNeurologyDrug DiscoveryMotor NeuroscienceNeuromuscular DisordersAmyotrophic Lateral SclerosisMuscle StrengthAdmet Property OptimizationMolecular Property OptimizationMuscle ActivationMuscle Contractile FunctionMuscle ForceMuscle Force GenerationMuscle Force ProductionPhase I Clinical Trials
muscle activation potency compared to the first-generation FSTA, tirasemtiv. Reldesemtiv demonstrated increased muscle force generation in a phase 1 clinical trial and is currently being evaluated in clinical trials for the treatment of amyotrophic lateral sclerosis.
18
Obesity Surgery · 1997 · 3.9K citations
Dennis R. Claflin, Lisa M. Larkin, Paul S. Cederna et al. · Journal of Applied Physiology · 2011 · 141 citations · Full text